TWI524890B - (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備 - Google Patents

(r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備 Download PDF

Info

Publication number
TWI524890B
TWI524890B TW099122740A TW99122740A TWI524890B TW I524890 B TWI524890 B TW I524890B TW 099122740 A TW099122740 A TW 099122740A TW 99122740 A TW99122740 A TW 99122740A TW I524890 B TWI524890 B TW I524890B
Authority
TW
Taiwan
Prior art keywords
cyclopropane
dimethyl
difluoro
fluoro
sulfonamide
Prior art date
Application number
TW099122740A
Other languages
English (en)
Chinese (zh)
Other versions
TW201113017A (en
Inventor
安卓雅斯 馬德娜
尚 米歇爾 維尼爾
Original Assignee
亞德生化公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI524890(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 亞德生化公司 filed Critical 亞德生化公司
Publication of TW201113017A publication Critical patent/TW201113017A/zh
Application granted granted Critical
Publication of TWI524890B publication Critical patent/TWI524890B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
TW099122740A 2009-07-24 2010-07-09 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備 TWI524890B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24

Publications (2)

Publication Number Publication Date
TW201113017A TW201113017A (en) 2011-04-16
TWI524890B true TWI524890B (zh) 2016-03-11

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099122740A TWI524890B (zh) 2009-07-24 2010-07-09 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備

Country Status (31)

Country Link
US (3) US8513443B2 (enExample)
EP (1) EP2462111B1 (enExample)
JP (1) JP5776115B2 (enExample)
KR (1) KR101763437B1 (enExample)
CN (2) CN103848808B (enExample)
AR (1) AR079183A1 (enExample)
AU (1) AU2010275780B2 (enExample)
BR (1) BR112012001592A2 (enExample)
CA (2) CA2768788C (enExample)
CL (1) CL2012000192A1 (enExample)
CO (1) CO6491075A2 (enExample)
CR (1) CR20120044A (enExample)
CU (1) CU24113B1 (enExample)
DO (1) DOP2012000017A (enExample)
EA (1) EA023623B1 (enExample)
EC (1) ECSP12011621A (enExample)
GT (1) GT201200017A (enExample)
HN (1) HN2012000142A (enExample)
IL (1) IL217312A (enExample)
IN (1) IN2012DN00696A (enExample)
MA (1) MA33452B1 (enExample)
MX (2) MX2012001063A (enExample)
MY (1) MY160421A (enExample)
NZ (1) NZ597738A (enExample)
PE (1) PE20120573A1 (enExample)
PH (1) PH12014500158B1 (enExample)
SG (1) SG177535A1 (enExample)
TN (1) TN2012000027A1 (enExample)
TW (1) TWI524890B (enExample)
UY (1) UY32800A (enExample)
WO (1) WO2011009541A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備
UA113850C2 (xx) * 2011-05-27 2017-03-27 Хіральний синтез n-{3,4-дифтор-2-$(2-фтор-4-йодфеніл)аміно]-6-метоксифеніл}-1-$2,3-дигідроксипропіл]циклопропансульфонамідів
EP2796455A4 (en) * 2011-12-19 2015-08-19 Sumitomo Chemical Co PROCESS FOR THE PREPARATION OF SULPHONATE
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495118B (zh) * 2005-07-21 2012-09-05 阿迪亚生命科学公司 Mek的n-(芳基氨基)磺酰胺抑制剂
US8101799B2 (en) 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
AU2007237901B2 (en) * 2006-04-18 2012-07-05 Ardea Biosciences, Inc. Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
CA2694646C (en) * 2007-07-30 2017-09-05 Ardea Biosciences, Inc. Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
CN102131771A (zh) * 2008-04-14 2011-07-20 阿迪生物科学公司 组合物及其制备和使用方法
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備

Also Published As

Publication number Publication date
EA201200175A1 (ru) 2012-12-28
CA2768788A1 (en) 2011-01-27
CO6491075A2 (es) 2012-07-31
MA33452B1 (fr) 2012-07-03
KR101763437B1 (ko) 2017-07-31
CL2012000192A1 (es) 2012-10-05
UY32800A (es) 2011-01-31
HN2012000142A (es) 2015-06-08
ECSP12011621A (es) 2012-02-29
CN102471246B (zh) 2015-08-26
IL217312A (en) 2017-02-28
JP5776115B2 (ja) 2015-09-09
US9296686B2 (en) 2016-03-29
TW201113017A (en) 2011-04-16
AU2010275780B2 (en) 2015-10-22
KR20120032536A (ko) 2012-04-05
PE20120573A1 (es) 2012-05-17
BR112012001592A2 (pt) 2016-03-08
PH12014500158A1 (en) 2015-09-07
MX2012001063A (es) 2012-03-26
US8513443B2 (en) 2013-08-20
AR079183A1 (es) 2012-01-04
CU24113B1 (es) 2015-08-27
IL217312A0 (en) 2012-02-29
AU2010275780A1 (en) 2012-02-02
CU20120014A7 (es) 2012-06-21
US20150274651A1 (en) 2015-10-01
US20130261320A1 (en) 2013-10-03
HK1198364A1 (zh) 2015-04-10
JP2013500242A (ja) 2013-01-07
CR20120044A (es) 2012-03-12
TN2012000027A1 (en) 2013-09-19
SG177535A1 (en) 2012-03-29
US8884058B2 (en) 2014-11-11
EA023623B1 (ru) 2016-06-30
CN103848808A (zh) 2014-06-11
CA2768788C (en) 2018-01-09
NZ597738A (en) 2014-03-28
CA2990097A1 (en) 2011-01-27
HK1171218A1 (en) 2013-03-22
DOP2012000017A (es) 2012-05-15
PH12014500158B1 (en) 2015-09-07
IN2012DN00696A (enExample) 2015-06-19
WO2011009541A1 (en) 2011-01-27
CN102471246A (zh) 2012-05-23
GT201200017A (es) 2013-12-19
MY160421A (en) 2017-03-15
US20120178946A1 (en) 2012-07-12
CN103848808B (zh) 2016-02-10
EP2462111B1 (en) 2016-03-30
EP2462111A1 (en) 2012-06-13
MX344965B (es) 2017-01-12

Similar Documents

Publication Publication Date Title
US20020151740A1 (en) Synthesis of vinyl carbonates for use in producing vinyl carbamates
US9296686B2 (en) Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
SE503179C2 (sv) Framställning av antihyperkolesterolemiska tetrazol- föreningar och mellanprodukter härför
Avenoza et al. An alternative approach to (S)-and (R)-2-methylglycidol O-benzyl ether derivatives
JP2022510740A (ja) ハリコンドリン系化合物の製造のための中間体及びその製造方法
AU2012264884B2 (en) Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides
HK1171218B (en) Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof
HK1198364B (en) Midbody of mek enzyme inhibitor
Razon et al. Primary and secondary allyltitanium (IV) reagents in aldehyde allylation II: Application to an enantioselective preparation of a C1-C7 fragment of spiramycin
JP5170987B2 (ja) 新規な含フッ素不飽和シリルエーテル化合物及び該化合物を中間体とする含フッ素不飽和アルコール誘導体の製造方法
RU2767880C1 (ru) Способ получения 1,3-диоксациклоалкилсодержащих азоокисей
JP5698128B2 (ja) ジヒドロキシヘキセン酸エステル及びその製造方法
JP2009215196A (ja) 光学活性ペルフルオロアルキル第2級アルコール誘導体の製造法
Antonevich et al. Synthesis of some flurophenyl 4-oxocyclopentane [d] isoxazolines and their dioxolane derivatives
JP2021038172A (ja) 4−ペンテン−2−イナールの製造方法
JP2012051812A (ja) 芳香族含フッ素非対称アシロイン化合物の製造方法

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees